Company registration number 08856777 (England and Wales)
BABAY MEDICAL LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025
BABAY MEDICAL LTD
CONTENTS
Page
Balance sheet and notes to the financial statements
1 - 2
BABAY MEDICAL LTD
BALANCE SHEET
AS AT 31 JANUARY 2025
31 January 2025
- 1 -
2025
2024
£
£
£
£
Fixed assets
12,017
22,603
Current assets
258,739
229,041
Creditors: amounts falling due within one year
(17,859)
(23,394)
Net current assets
240,880
205,647
Total assets less current liabilities
252,897
228,250
Net assets
252,897
228,250
Capital and reserves
252,897
228,250
Notes to the financial statements
1
Directors' benefits: advances, credit and guarantees

Babatunde Salako

Balance outstanding at start of period        3,336

Amounts advanced                -

Amounts repaid                    3,336

Amounts written off                -

Amounts waived                    -

Balance outstanding at end of period        -

 

 

The loan was unsecured and repaid in full.

2
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2025
2024
Number
Number
Employees
0
-

Babay Medical Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Soho House, 362 - 364 Soho Road, Birmingham, UK, B21 9QL.

For the year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

BABAY MEDICAL LTD
BALANCE SHEET (CONTINUED)
AS AT 31 JANUARY 2025
31 January 2025
- 2 -

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime', and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 13 October 2025 and are signed on its behalf by:
Dr Babatunde Salako
Director
Company Registration Number 08856777
2025-01-312024-02-01falsefalseCCH SoftwareCCH Accounts Production 2025.200No description of principal activityDr Babatunde SalakoRamat Salakofalse088567772024-02-012025-01-31088567772025-01-31088567772024-01-3108856777core:CurrentFinancialInstrumentscore:WithinOneYear2025-01-3108856777core:CurrentFinancialInstrumentscore:WithinOneYear2024-01-3108856777bus:Director12024-02-012025-01-3108856777bus:PrivateLimitedCompanyLtd2024-02-012025-01-3108856777bus:SmallCompaniesRegimeForAccounts2024-02-012025-01-3108856777bus:Micro-entities2024-02-012025-01-3108856777bus:AuditExemptWithAccountantsReport2024-02-012025-01-3108856777bus:Director22024-02-012025-01-3108856777bus:FullAccounts2024-02-012025-01-31xbrli:purexbrli:sharesiso4217:GBP